DK0571264T3 - Self-adhesive matrix system for the transdermal, long-lasting delivery of piribedil - Google Patents

Self-adhesive matrix system for the transdermal, long-lasting delivery of piribedil

Info

Publication number
DK0571264T3
DK0571264T3 DK93401262T DK93401262T DK0571264T3 DK 0571264 T3 DK0571264 T3 DK 0571264T3 DK 93401262 T DK93401262 T DK 93401262T DK 93401262 T DK93401262 T DK 93401262T DK 0571264 T3 DK0571264 T3 DK 0571264T3
Authority
DK
Denmark
Prior art keywords
piribedil
self
transdermal
long
matrix system
Prior art date
Application number
DK93401262T
Other languages
Danish (da)
Inventor
Fran Oise Arnaud
Gerald Pichon
Alain Cuine
Isabelle Rault
Olivier Crambes
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0571264T3 publication Critical patent/DK0571264T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Matrix system made up of ethylene/vinyl acetate copolymer, self-adhesive for the extended release of piribedil. This system ensures the continuous and uniform diffusion of piribedil by a transcutaneous route.
DK93401262T 1992-05-19 1993-05-18 Self-adhesive matrix system for the transdermal, long-lasting delivery of piribedil DK0571264T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9206037A FR2691361B1 (en) 1992-05-19 1992-05-19 SELF-ADHESIVE MATRIX SYSTEM FOR THE EXTENDED RELEASE OF THE PIRIBEDIL BY TRANSCUTANEOUS ROUTE.

Publications (1)

Publication Number Publication Date
DK0571264T3 true DK0571264T3 (en) 1999-08-09

Family

ID=9429912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93401262T DK0571264T3 (en) 1992-05-19 1993-05-18 Self-adhesive matrix system for the transdermal, long-lasting delivery of piribedil

Country Status (11)

Country Link
EP (1) EP0571264B1 (en)
JP (1) JPH0632738A (en)
AT (1) ATE173623T1 (en)
AU (1) AU656266B2 (en)
CA (1) CA2096511A1 (en)
DE (1) DE69322201T2 (en)
DK (1) DK0571264T3 (en)
ES (1) ES2127259T3 (en)
FR (1) FR2691361B1 (en)
NZ (1) NZ247648A (en)
ZA (1) ZA933508B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675383B1 (en) * 1991-04-18 1995-05-12 Bernard Aranda USE OF A MEDICINAL PRODUCT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HYPERACTIVE OR UNSTABLE BLADDER.
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
FR2744130B1 (en) * 1996-01-31 1998-03-20 Atohaas Holding Cv ADHESIVE COMPOSITION FOR (CO) POLYMER (METH) ACRYLIC MATERIALS
CN103373991A (en) * 2013-07-12 2013-10-30 安徽安腾药业有限责任公司 Method for preparing piribedil in high-purity high-yield manner

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (en) * 1976-06-23 1978-01-20 Roussel Uclaf APPLICATION AS A MEDICINAL PRODUCT OF A DERIVATIVE OF PIPERAZINE AND ITS SALTS
AU630347B2 (en) * 1988-02-26 1992-10-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
FR2664815B1 (en) 1990-07-23 1994-11-04 Adir SELF-ADHESIVE MATRIX SYSTEM FOR THE EXTENDED RELEASE OF THE PIRIBEDIL BY TRANSCUTANEOUS ROUTE.
GB9102089D0 (en) * 1991-01-31 1991-03-13 Johnson & Johnson Medical Net wound dressings

Also Published As

Publication number Publication date
ZA933508B (en) 1993-12-10
DE69322201D1 (en) 1999-01-07
EP0571264B1 (en) 1998-11-25
ATE173623T1 (en) 1998-12-15
EP0571264A1 (en) 1993-11-24
AU3860793A (en) 1993-11-25
AU656266B2 (en) 1995-01-27
DE69322201T2 (en) 1999-06-24
FR2691361B1 (en) 1994-07-08
JPH0632738A (en) 1994-02-08
CA2096511A1 (en) 1993-11-20
NZ247648A (en) 1995-01-27
FR2691361A1 (en) 1993-11-26
ES2127259T3 (en) 1999-04-16

Similar Documents

Publication Publication Date Title
DK288987D0 (en) A DELIVERY SYSTEM FOR THE DOSAGE FORMS DELAYED DELIVERY AND ITS PREPARATION
FI955215A (en) Controlled release oxybutynin preparations
ATE244582T1 (en) DERMAL THERAPEUTIC SYSTEM MADE OF A FUSABLE POLY(METH)-ACRYLATE MIXTURE
BR9407238A (en) Implantable drug delivery device
DE68915162D1 (en) NEEDLE-FREE, ONE-WAY INJECTION SYSTEM.
DK0598606T3 (en) Extrudable compositions for topical transdermal drug delivery
NO950651L (en) Antitranspirasjonsdeodorantpreparat
DE3872059D1 (en) METHOD AND DEVICES FOR DISTRIBUTING FRAGRANCES.
NL187611C (en) STERILIZATION ATTACHMENT INTENDED FOR INSTALLATION AT THE NEEDLE HOLDER OF AN INJECTION SYRINGE.
FI954989A (en) The medicated plaster
CA2309818A1 (en) Buffered drug formulations for transdermal electrotransport delivery
NZ230470A (en) Controlled release device coated with one or more asymmetric membranes, and preparation thereof
MY109271A (en) Ozone-friendly correction fluid containing a butyl methacrylate copolymer as a film forming binder
DE69300643D1 (en) RF-curable type I wood adhesive composition with vinyl acetate / N-methylolacrylamide copolymer emulsions containing tetramethylolglycolouril.
DK0571264T3 (en) Self-adhesive matrix system for the transdermal, long-lasting delivery of piribedil
DK15789D0 (en) AZOL-SUBSTITUTED CYCLOAL CHANNEL DERIVATIVES, PROCEDURES FOR THE PRODUCTION THEREOF, AND USE OF THE DERIVATIVES AS AGRICULTURAL AND MARINE FUNGICIDES.
DK0468875T3 (en) Self-adhesive matrix system for extended release of piribedil by transcutaneous pathway
DE3673171D1 (en) SOLUBLE, CROSSLINKABLE ACRYLATE COPOLYMER, METHOD FOR THE PRODUCTION THEREOF AND COATING AGENTS BASED ON THE ACRYLATE COPOLYMER.
DK0508095T3 (en) Dental materials based on (meth) acrylates
FI101855B1 (en) A process for preparing an acetazolamide sustained release formulation
ATE219665T1 (en) DOSAGE FORMS AND USES THEREOF
ITTO920561A1 (en) DRUG INFUSION DEVICE, ESPECIALLY FOR FERROCHELING THERAPIES.
ES2154392T3 (en) THERMOFUSIBLE ADHESIVE COMPOSITIONS BASED ON COPOLYMERS THAT INCLUDE ETHYLENE, VINYL ACETATE AND VINYLALCOXISILANE.
NO891277L (en) DISTRIBUTOR DEVICE FOR TELECOMMUNICATION SYSTEMS.
DE69206197D1 (en) Polymer dispersions of vinyl pivalate, vinyl acetate and alkylene.